Université de Montréal

About: Université de Montréal is a education organization based out in Montreal, Quebec, Canada. It is known for research contribution in the topics: Population & Context (language use). The organization has 45641 authors who have published 100476 publications receiving 4004007 citations. The organization is also known as: University of Montreal & UdeM.

Varieties of musical disorders. The Montreal Battery of Evaluation of Amusia.

Abstract: Multiple disorders of musical abilities can occur after brain damage. Conversely, early brain anomalies or vast brain injuries may sometimes spare ordinary musical skills in individuals who experience severe cognitive losses. To document these incidences, comprehensive behavioral testing is required. We propose to use the Montreal Battery of Evaluation of Amusia (MBEA) because it is arguably the best tool currently available. Over the last decade, this battery was developed and validated in populations with brain damage of various etiologies. Furthermore, the MBEA is theoretically motivated and satisfies important psychometric properties. It is sensitive, normally distributed, reliable on test-retest, and correlates with Gordon's Musical Aptitude Profile, another more widely used battery of tests. To promote its wide usage, the MBEA is now available upon request. In addition, individual MBEA data of 160 normal participants of variable age and education have been made available to all via the internet.

The Importance of Skip Connections in Biomedical Image Segmentation

Abstract: In this paper, we study the influence of both long and short skip connections on Fully Convolutional Networks (FCN) for biomedical image segmentation. In standard FCNs, only long skip connections are used to skip features from the contracting path to the expanding path in order to recover spatial information lost during downsampling. We extend FCNs by adding short skip connections, that are similar to the ones introduced in residual networks, in order to build very deep FCNs (of hundreds of layers). A review of the gradient flow confirms that for a very deep FCN it is beneficial to have both long and short skip connections. Finally, we show that a very deep FCN can achieve near-to-state-of-the-art results on the EM dataset without any further post-processing.

Evidence for an excess of B̄→D( *)τ -ν ̄τ decays

Abstract: Based on the full BaBar data sample, we report improved measurements of the ratios R(D(*)) = B(B -> D(*) Tau Nu)/B(B -> D(*) l Nu), where l is either e or mu. These ratios are sensitive to new physics contributions in the form of a charged Higgs boson. We measure R(D) = 0.440 +- 0.058 +- 0.042 and R(D*) = 0.332 +- 0.024 +- 0.018, which exceed the Standard Model expectations by 2.0 sigma and 2.7 sigma, respectively. Taken together, our results disagree with these expectations at the 3.4 sigma level. This excess cannot be explained by a charged Higgs boson in the type II two-Higgs-doublet model. We also report the observation of the decay B -> D Tau Nu, with a significance of 6.8 sigma.

Coronary Bypass Surgery with or without Surgical Ventricular Reconstruction

Abstract: Background Surgical ventricular reconstruction is a specific procedure designed to reduce left ventricular volume in patients with heart failure caused by coronary artery disease. We conducted a trial to address the question of whether surgical ventricular reconstruction added to coronary-artery bypass grafting (CABG) would decrease the rate of death or hospitalization for cardiac causes, as compared with CABG alone. Methods Between September 2002 and January 2006, a total of 1000 patients with an ejection fraction of 35% or less, coronary artery disease that was amenable to CABG, and dominant anterior left ventricular dysfunction that was amenable to surgical ventricular reconstruction were randomly assigned to undergo either CABG alone (499 patients) or CABG with surgical ventricular reconstruction (501 patients). The primary outcome was a composite of death from any cause and hospitalization for cardiac causes. The median follow-up was 48 months. Results Surgical ventricular reconstruction reduced the end-systolic volume index by 19%, as compared with a reduction of 6% with CABG alone. Cardiac symptoms and exercise tolerance improved from baseline to a similar degree in the two study groups. However, no significant difference was observed in the primary outcome, which occurred in 292 patients (59%) who were assigned to undergo CABG alone and in 289 patients (58%) who were assigned to undergo CABG with surgical ventricular reconstruction (hazard ratio for the combined approach, 0.99; 95% confidence interval, 0.84 to 1.17; P = 0.90). Conclusions Adding surgical ventricular reconstruction to CABG reduced the left ventricular volume, as compared with CABG alone. However, this anatomical change was not associated with a greater improvement in symptoms or exercise tolerance or with a reduction in the rate of death or hospitalization for cardiac causes. (ClinicalTrials. gov number, NCT00023595.)

The biology and therapeutic targeting of the proprotein convertases

Abstract: The mammalian proprotein convertases constitute a family of nine secretory serine proteases that are related to bacterial subtilisin and yeast kexin. Seven of these (proprotein convertase 1 (PC1), PC2, furin, PC4, PC5, paired basic amino acid cleaving enzyme 4 (PACE4) and PC7) activate cellular and pathogenic precursor proteins by cleavage at single or paired basic residues, whereas subtilisin kexin isozyme 1 (SKI-1) and proprotein convertase subtilisin kexin 9 (PCSK9) regulate cholesterol and/or lipid homeostasis via cleavage at non-basic residues or through induced degradation of receptors. Proprotein convertases are now considered to be attractive targets for the development of powerful novel therapeutics. In this Review, we summarize the physiological functions and pathological implications of the proprotein convertases, and discuss proposed strategies to control some of their activities, including their therapeutic application and validation in selected disease states.